(Q34450803)

2 August 2017

1 reference

title

Movement dysfunction and hepatic encephalopathy (English)

1 reference

2 August 2017

Layrargues GP

1

1 reference

2 August 2017

language of work or name

1 reference

1 June 2001

1 reference

2 August 2017

published in

Metabolic Brain Disease

1 reference

2 August 2017

volume

16

1 reference

2 August 2017

issue

1-2

1 reference

2 August 2017

page(s)

27-35

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1011658311004

2 August 2017

exact match

0 references

cites work

Manganese and chronic hepatic encephalopathy

1 reference

12 December 2020

Distribution of cerebral lesions in acquired hepatocerebral degeneration

1 reference

12 December 2020

Increased manganese concentrations in pallidum of cirrhotic patients

1 reference

12 December 2020

Proton magnetic resonance spectroscopy in portal-systemic encephalopathy

1 reference

12 December 2020

Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial

1 reference

12 December 2020

Fine structure of inclusion body in the nucleus of Alzheimer glia type II in the brain of hepatocerebral degeneration

1 reference

12 December 2020

Treatment of chronic portal systemic encephalopathy with bromocriptine: a double-blind controlled trial

1 reference

12 December 2020

Direction of splenic venous flow assessed by pulsed Doppler flowmetry in patients with a large splenorenal shunt. Relation to spontaneous hepatic encephalopathy.

1 reference

12 December 2020

Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis

1 reference

12 December 2020

Ammonia: key factor in the pathogenesis of hepatic encephalopathy

1 reference

12 December 2020

Brain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1-weighted images and elemental concentrations in brain

1 reference

12 December 2020

Dystonia, hyperintense basal ganglia, and high whole blood manganese levels in Alagille's syndrome.

1 reference

12 December 2020

Treatment of chronic hepatic encephalopathy with levodopa

1 reference

12 December 2020

Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease

1 reference

12 December 2020

Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations

1 reference

12 December 2020

The neurobiology of hepatic encephalopathy

1 reference

12 December 2020

Movement disorders in alcoholism: a review

1 reference

12 December 2020

Accumulation of manganese and copper in pallidum of cirrhotic patients: role in the pathogenesis of hepatic encephalopathy?

1 reference

12 December 2020

Chronic manganese poisoning: a neuropathological study with determination of manganese distribution in the brain

1 reference

12 December 2020

MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status

1 reference

12 December 2020

Successful use of bromocriptine in the treatment of chronic hepatic encephalopathy

1 reference

12 December 2020

Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis.

1 reference

12 December 2020

Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms

1 reference

12 December 2020

Role of manganese in the pathogenesis of portal-systemic encephalopathy

1 reference

12 December 2020

Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure.

1 reference

12 December 2020

The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration

1 reference

12 December 2020

Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation.

1 reference

12 December 2020

MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation.

1 reference

12 December 2020

Neurologic Disorders and Liver Disease

1 reference

12 December 2020

Acquired hepatocerebral degeneration: MR similarity with Wilson disease

1 reference

12 December 2020

Restoration of portal venous perfusion and reversal of encephalopathy by balloon occlusion of portal systemic shunt.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1011658311004

1 reference

Dimensions Publication ID

2 August 2017

1038153607

0 references

1 reference